In the recent years, DNMT3A (DNA (cytosine-5-)-methyltransferase 3 alpha) and TET2 gene mutations affecting DNA methylation, are detected by genome sequencing in many myeloproliferative neoplasms [43,46,47]. The gene discussed is DNMT3A; the disease is myeloproliferative disorder.